What Makes a Biomarker Actually Useful

A biomarker is useful only when it reliably measures something that matters and, crucially, when knowing it changes a decision. Plenty of biomarkers are accurate and interesting yet useless in practice, because the number, however precise, does not lead to a different or better action. The bar for a useful one is higher than measurability: it must be valid, reliable, and decision-relevant. This is a method article, not medical advice; for your own care, rely on a clinician.

I have worked with biomarkers from both the lab and the clinic, in diabetes genetics and in building decision-support tools that turn measurements into recommendations. The recurring lesson is that the hard part is never measuring something. It is showing that the measurement deserves to influence what you do.

Start with what it is supposed to do

A biomarker is a measurable signal, often from blood, imaging, or genetics, used to indicate something about health that is harder to observe directly. Before judging one, ask what job it is meant to do, because the standards differ. A diagnostic biomarker tells you whether a condition is present. A prognostic one tells you how things are likely to unfold. A predictive one tells you who is likely to respond to a particular approach. Each role demands different evidence, and a biomarker good at one job may be poor at another.

The most common confusion is treating any of these as if it were a surrogate for outcomes. A marker that tracks with a disease is not automatically a marker that, when changed, changes the disease. Conflating the two is one of the oldest traps in medicine, and a careful reader keeps the roles separate.

Validity: does it measure the right thing

Validity is whether the biomarker actually reflects the biology you care about. A marker can be exquisitely measurable and still be measuring the wrong thing, or measuring something only loosely connected to the outcome that matters. The question is not "can we detect it" but "does detecting it tell us something true about the patient's condition or future."

This is where many promising markers fall short. They correlate with a disease in one dataset, which is encouraging, but correlation in a single sample is a weak foundation. Real validity shows up when the relationship holds across different populations and settings, which is exactly the kind of generalizability that diabetes research has learned not to take for granted.

Reliability: does it measure the same thing twice

Reliability is whether the biomarker gives consistent results under the same conditions. If the same sample produces meaningfully different readings depending on the lab, the day, or the method, the marker is hard to act on, because you cannot tell a real change from measurement noise. A useful biomarker is stable enough that a change in the number reflects a change in the patient, not a change in the instrument.

Reliability also covers the practical questions that decide whether a marker survives contact with real clinics: can it be measured affordably, repeatedly, and the same way across the places it will be used. A marker that only works in a research lab under ideal conditions rarely becomes useful at scale.

The decisive test: does it change a decision

Here is the question that retires most biomarkers: if you knew this number, would you do anything differently, and would the patient be better for it. A biomarker that is valid and reliable but does not change management is a curiosity, not a clinical tool. The value of a measurement is realized only in the action it enables.

This is also the honest standard for a new biomarker making bold claims. Ask not only whether it predicts something, but whether acting on the prediction has been shown to help. The strongest evidence is a study where using the biomarker to guide decisions led to better outcomes than not using it. Short of that, a marker remains promising rather than proven, and saying so plainly is a service to everyone.

A short way to judge one

When you meet a new biomarker, run it through four questions. What job is it for, diagnosis, prognosis, or prediction. Does it truly reflect the biology, across more than one population. Is it stable and practical to measure the same way repeatedly. And does knowing it change what a clinician does, in a way shown to help. A marker that answers all four has earned a place. One that stops at "we can measure it and it correlates" is at the beginning of the journey, not the end.

None of this is a knock on the many researchers developing new markers, which is genuinely hard and genuinely valuable work. It is simply the discipline that protects patients from acting on numbers that look meaningful before they have proven they are.